RCEL

RCEL R&D Expense Growth

2.35%Fiscal year

Period ending:

RCEL FY R&D Growth (YoY)%
RCEL FY R&D Growth (YoY)401.31%-125.22%
1993-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year. Growth compares with the corresponding period one year earlier.

RCEL r&d expense growth history

Year-over-year research & development expense growth. The available annual fiscal periods series contains 33 observations from Dec 31, 1993 to Dec 31, 2025.

Avita Medical Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
2.3527%
-2.2141%
50.2562%
-11.5642%
5.743%
61.6979%
-19.951%
-13.6929%
110.7494%
82.3094%
-9.425%
76.4836%
-16.0947%
159.53%
350.359%
12.7517%
-5.9009%
29.9543%
-74.2666%
-65.7998%
17.3764%
155.4472%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%

Compare r&d expense growth

All RCEL financial metrics · RCEL stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.